Japan Reports Modest, But Positive Effect Of Generic-Drug Emphasis
This article was originally published in PharmAsia News
In Japan, where an emphasis on buying generic drugs began in April 2008, the class of medicine comprised 7.2 percent of spending on prescription drugs. The increase, however, was only a 0.4 percent increase of 2007, the Ministry of Health, Labor and Welfare said. The ministry said the figures indicate the proportion of generics usage is still low, but that at least the change in policy has had an effect. Generics use amounted to 21.1 percent of drugs dispensed for treating blood and other bodily fluid problems in hospital settings. (Click here for more - a subscription may be required
You may also be interested in...
Final data comparing cabotegravir to Truvada for HIV prophylaxis confirms superiority. ViiV says treatment data in women may enable an all-gender approval that eluded Gilead with Descovy.
Regulators in high-income countries have a responsibility to help health authorities in low- and medium- income countries develop regulatory frameworks for cell and gene therapy products to ensure these treatments are available to all, asserts the US FDA’s biologics center’s director.
Democratic lawmakers argue the Trump administration’s interpretation of how COVID-19 testing is covered by private insurers runs contrary to the Families First Act and CARES Act. They want the administration to update a FAQ sheet that eliminates certain prerequisites that would qualify patients to be reimbursed for the tests.